Conference
Onyx-3, a double-blind comparison of once- or twice-daily dosing with YM150 (30 or 60 mg daily) for preventing venous thromboembolism after elective hip arthroplasty
Authors
Eriksson B; Agnelli G; Gallus AS; Lassen MR; Prins MH; Renfurm RW; Turpie AGG
Volume
9
Pagination
pp. 855-855
Publisher
WILEY-BLACKWELL
Publication Date
July 1, 2011
Conference proceedings
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
ISSN
1538-7933